CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79.75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Open platformOpen platform

Cogent Biosciences Grants 22,000 Stock Options, 16,500 RSUs to Six New Employees

By Public Technologies
  • Cogent Biosciences granted equity awards to six new employees on October 26, 2026, under its 2020 Inducement Plan.
  • The awards comprised nonqualified options to purchase 22,000 common shares and 16,500 restricted stock units.
  • Options have 10-year terms, with 25% vesting on the grant date's first anniversary.
  • Remaining options vest in equal monthly installments over the subsequent 36 months; restricted stock units vest annually in equal installments over four years.
  • All vesting requires continued employment through each vesting date.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cogent Biosciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610271601PRIMZONEFULLFEED9854346) on October 27, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.